Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Colditz G. A., Hankinson S. E., Hunter D. J., Willett W. C., Manson J. E., Stampfer M. J., Hennekens C., Rosner B., Speizer F. E. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med. 1995 Jun 15;332(24):1589–1593. doi: 10.1056/NEJM199506153322401. [DOI] [PubMed] [Google Scholar]
- Folsom A. R., Mink P. J., Sellers T. A., Hong C. P., Zheng W., Potter J. D. Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women. Am J Public Health. 1995 Aug;85(8 Pt 1):1128–1132. doi: 10.2105/ajph.85.8_pt_1.1128. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Isaacs A. J., Britton A. R., McPherson K. Utilisation of hormone replacement therapy by women doctors. BMJ. 1995 Nov 25;311(7017):1399–1401. doi: 10.1136/bmj.311.7017.1399. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McPherson K. Breast cancer and hormonal supplements in postmenopausal women. BMJ. 1995 Sep 16;311(7007):699–700. doi: 10.1136/bmj.311.7007.699. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Price E. H., Little H. K. Women need to be fully informed about risks of hormone replacement therapy. BMJ. 1996 May 18;312(7041):1301–1301. doi: 10.1136/bmj.312.7041.1301. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stanford J. L., Weiss N. S., Voigt L. F., Daling J. R., Habel L. A., Rossing M. A. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA. 1995 Jul 12;274(2):137–142. [PubMed] [Google Scholar]